ClavystBio — Full Portfolio

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.

BiotechDeep TechHealthtechLeiden, NL

KWKoenraad Wiedhaup(Founder & Chief Executive Officer)inRBRonald Brus(Founder & Chief Growth Officer)inJGJaap Goudsmit(Founding Scientist and Senior Advisor)inDVDinko Valerio(Founder and Chair of the Supervisory Board)inJAJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in

Co-investorsF-F-Prime CapitalGVGV (Google Ventures)BLBluebird VenturesBYByers CapitalCACasdin CapitalEUEuropean Innovation Council Fund+7 more

65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.

BiotechDeep TechSingapore, SG

BoardSteve Courtney(Expert in Residence)

Co-investorsLILightstone VenturesLELeaps by Bayer

Allay Therapeutics develops localized pain management technology designed to deliver several weeks of post-surgical pain relief.

BiotechHealthtechMedical DevicesSan Jose, US

AGAdam Gridley(Executive Officer, Director)inKristen Howells(Executive Officer)inJosh Makower(Director)Tak Cheung(Director)inKarun D. Naga(Executive Officer, Director)

BoardLeighton Read(Director)

Co-investorsARArboretum VenturesLILightstone VenturesNENew Enterprise Associates (NEA)SGSGInnovateEVEvonik Venture Capital GmbH

Automera develops an autophagy-powered small molecule degrader platform designed to accelerate drug development and reduce costs in therapeutic creation.

AI & Machine LearningBiotechDeep Tech

Zian-Loong Wang(Chief Technology Officer & Co-Founder)MLMichael Lazarou(Co-Founder)inTQThong Q. Le(Chief Executive Officer)in

Co-investorsACACCELERATOR LIFE SCIENCE PARTNERSXOXora Innovation Pte Ltd

Cirrus Therapeutics is a biotech developing gene and cell therapies based on ocular immunology to treat dry age-related macular degeneration (AMD), including an AAV gene therapy to restore the IRAK-M immune regulator and a next-generation retinal pigment epithelium (RPE) cell therapy for advanced geographic atrophy.

BiotechHealthtechLongevityCambridge, US

YKYing Kai Chan(Co-founder & CEO)inAndrew Dick(Director, Promoter)

BoardACAlexandra Cantley(Director)inKhoo Shih(Director)

Co-investorsZAZAKA VCPOPolaris Partners

Droia Ventures is a specialist venture capital firm investing globally in early-stage drug development companies focused on therapeutics for oncology and genetic disease.

BiotechLeuven, BE

Co-investorsFRFrazier Life SciencesLILifeArc VenturesNONovo Holdings

Engine Bio presents itself as a company working on new cancer medicines.

BiotechSingapore, SG

DTDaphne Teo(Founder)in

Co-investorsNSNSG VenturesWIWI Harper GroupPOPolaris Partners

Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.

AI & Machine LearningBiotechDeep TechHealthtech

PIPiers Ingram(Chief Executive Officer, Co-Founder, Executive Director)inJBJerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inKonrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)DTDipti Thakkar(Chief Operating Officer)in

Co-investorsALAltium CapitalDEDecheng CapitalDRDroia VenturesFRFrazier Life SciencesKIKiwoom InvestmentMUMuirwoods Ventures+6 more

NSG Bio operates BSL-2 certified co-working wet-laboratory and office spaces for life sciences and biotech companies in Singapore, offering turnkey facilities, shared equipment, and support services for startups and multinationals conducting R&D.

BiotechPropTechSingapore, SG

DTDaphne Teo(Founder)in

Co-investorsNSNSG Ventures

Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.

BiotechDigital HealthHealthtechMedical DevicesSingapore, SG

Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMSMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in

Co-investorsANAngelini VenturesKUKurma PartnersBOBoehringer Ingelheim Venture FundHIHighlight CapitalSESEEDS Capital

Paratus Sciences is a drug discovery company that uses AI-powered methods to identify first-in-class medicines by studying evolutionary traits, targeting serious diseases where current therapies are inadequate.

AI & Machine LearningBiotechDeep TechUnited States, US

Co-investorsARARCH Venture PartnersECEcoR1 CapitalLELeaps by Bayer

Polaris Partners is an investment firm with nearly 30 years of experience backing healthcare and biotech companies, focusing on innovative care delivery, digital health, consumer-centric businesses, therapeutics, and genomics.

BiotechDigital HealthHealthtech

Co-investorsWSWSS

Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.

BiotechFemTechHealthtechMedical DevicesBedford, US

ASAmar Sawhney(Founder)inNICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)

BoardTARA BUTLER(Executive Officer, Director, Promoter)

Co-investorsASAscension VenturesCACatalyst Health VenturesDEDelos CapitalFEFemHealth VenturesIYIyengar Capital PartnersSPSparta Group+1 more

Biotechnology company developing blood-based diagnostic tests for neurological disorders and early-stage cancer.

Cambridge, US

Co-investorsALAlumni VenturesARARCH Venture PartnersPOPolaris PartnersS3S32